Global Brain Disease Device and Software 麻豆原创 Research Report 2023

Publication ID:

PB501232683

Publication Date:

January 20, 2023

Pages:

103

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Highlights
The global Brain Disease Device and Software market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Brain Disease Device and Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Brain Disease Device and Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Brain Disease Device and Software in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Brain Disease Device and Software include United Imaging Healthcare Co., Ltd, Koninklijke Philips N.V., GE, Canon, Inc, Siemens Healthineers AG, Vuno Co., Ltd, Fujifilm Holdings Corporation, Aspect Imaging and IXICO, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brain Disease Device and Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Disease Device and Software.
The Brain Disease Device and Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Brain Disease Device and Software market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Disease Device and Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
United Imaging Healthcare Co., Ltd
Koninklijke Philips N.V.
GE
Canon, Inc
Siemens Healthineers AG
Vuno Co., Ltd
Fujifilm Holdings Corporation
Aspect Imaging
IXICO
QMENTA
Cortechs.ai
Quantib
Brainomix
Qure.AI
Imaging Biometrics, LLC
A.I. Analysis, Inc
Segment by Type
Brain Disease Device
Brain Disease Software
Segment by Application
Hospitals and Clinics
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Disease Device and Software companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Brain Disease Device and Software 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brain Disease Device
1.2.3 Brain Disease Software
1.3 麻豆原创 by Application
1.3.1 Global Brain Disease Device and Software 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Imaging Centers
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Disease Device and Software 麻豆原创 Perspective (2018-2029)
2.2 Brain Disease Device and Software Growth Trends by Region
2.2.1 Global Brain Disease Device and Software 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Brain Disease Device and Software Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Brain Disease Device and Software Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Brain Disease Device and Software 麻豆原创 Dynamics
2.3.1 Brain Disease Device and Software Industry Trends
2.3.2 Brain Disease Device and Software 麻豆原创 Drivers
2.3.3 Brain Disease Device and Software 麻豆原创 Challenges
2.3.4 Brain Disease Device and Software 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Disease Device and Software Players by Revenue
3.1.1 Global Top Brain Disease Device and Software Players by Revenue (2018-2023)
3.1.2 Global Brain Disease Device and Software Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Brain Disease Device and Software 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Disease Device and Software Revenue
3.4 Global Brain Disease Device and Software 麻豆原创 Concentration Ratio
3.4.1 Global Brain Disease Device and Software 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Disease Device and Software Revenue in 2022
3.5 Brain Disease Device and Software Key Players Head office and Area Served
3.6 Key Players Brain Disease Device and Software Product Solution and Service
3.7 Date of Enter into Brain Disease Device and Software 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Disease Device and Software Breakdown Data by Type
4.1 Global Brain Disease Device and Software Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Brain Disease Device and Software Forecasted 麻豆原创 Size by Type (2024-2029)
5 Brain Disease Device and Software Breakdown Data by Application
5.1 Global Brain Disease Device and Software Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Brain Disease Device and Software Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Brain Disease Device and Software 麻豆原创 Size (2018-2029)
6.2 North America Brain Disease Device and Software 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Brain Disease Device and Software 麻豆原创 Size by Country (2018-2023)
6.4 North America Brain Disease Device and Software 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Disease Device and Software 麻豆原创 Size (2018-2029)
7.2 Europe Brain Disease Device and Software 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Brain Disease Device and Software 麻豆原创 Size by Country (2018-2023)
7.4 Europe Brain Disease Device and Software 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Disease Device and Software 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Brain Disease Device and Software 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Brain Disease Device and Software 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Brain Disease Device and Software 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Disease Device and Software 麻豆原创 Size (2018-2029)
9.2 Latin America Brain Disease Device and Software 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Brain Disease Device and Software 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Brain Disease Device and Software 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Disease Device and Software 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Brain Disease Device and Software 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Brain Disease Device and Software 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Brain Disease Device and Software 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United Imaging Healthcare Co., Ltd
11.1.1 United Imaging Healthcare Co., Ltd Company Detail
11.1.2 United Imaging Healthcare Co., Ltd Business Overview
11.1.3 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Introduction
11.1.4 United Imaging Healthcare Co., Ltd Revenue in Brain Disease Device and Software Business (2018-2023)
11.1.5 United Imaging Healthcare Co., Ltd Recent Development
11.2 Koninklijke Philips N.V.
11.2.1 Koninklijke Philips N.V. Company Detail
11.2.2 Koninklijke Philips N.V. Business Overview
11.2.3 Koninklijke Philips N.V. Brain Disease Device and Software Introduction
11.2.4 Koninklijke Philips N.V. Revenue in Brain Disease Device and Software Business (2018-2023)
11.2.5 Koninklijke Philips N.V. Recent Development
11.3 GE
11.3.1 GE Company Detail
11.3.2 GE Business Overview
11.3.3 GE Brain Disease Device and Software Introduction
11.3.4 GE Revenue in Brain Disease Device and Software Business (2018-2023)
11.3.5 GE Recent Development
11.4 Canon, Inc
11.4.1 Canon, Inc Company Detail
11.4.2 Canon, Inc Business Overview
11.4.3 Canon, Inc Brain Disease Device and Software Introduction
11.4.4 Canon, Inc Revenue in Brain Disease Device and Software Business (2018-2023)
11.4.5 Canon, Inc Recent Development
11.5 Siemens Healthineers AG
11.5.1 Siemens Healthineers AG Company Detail
11.5.2 Siemens Healthineers AG Business Overview
11.5.3 Siemens Healthineers AG Brain Disease Device and Software Introduction
11.5.4 Siemens Healthineers AG Revenue in Brain Disease Device and Software Business (2018-2023)
11.5.5 Siemens Healthineers AG Recent Development
11.6 Vuno Co., Ltd
11.6.1 Vuno Co., Ltd Company Detail
11.6.2 Vuno Co., Ltd Business Overview
11.6.3 Vuno Co., Ltd Brain Disease Device and Software Introduction
11.6.4 Vuno Co., Ltd Revenue in Brain Disease Device and Software Business (2018-2023)
11.6.5 Vuno Co., Ltd Recent Development
11.7 Fujifilm Holdings Corporation
11.7.1 Fujifilm Holdings Corporation Company Detail
11.7.2 Fujifilm Holdings Corporation Business Overview
11.7.3 Fujifilm Holdings Corporation Brain Disease Device and Software Introduction
11.7.4 Fujifilm Holdings Corporation Revenue in Brain Disease Device and Software Business (2018-2023)
11.7.5 Fujifilm Holdings Corporation Recent Development
11.8 Aspect Imaging
11.8.1 Aspect Imaging Company Detail
11.8.2 Aspect Imaging Business Overview
11.8.3 Aspect Imaging Brain Disease Device and Software Introduction
11.8.4 Aspect Imaging Revenue in Brain Disease Device and Software Business (2018-2023)
11.8.5 Aspect Imaging Recent Development
11.9 IXICO
11.9.1 IXICO Company Detail
11.9.2 IXICO Business Overview
11.9.3 IXICO Brain Disease Device and Software Introduction
11.9.4 IXICO Revenue in Brain Disease Device and Software Business (2018-2023)
11.9.5 IXICO Recent Development
11.10 QMENTA
11.10.1 QMENTA Company Detail
11.10.2 QMENTA Business Overview
11.10.3 QMENTA Brain Disease Device and Software Introduction
11.10.4 QMENTA Revenue in Brain Disease Device and Software Business (2018-2023)
11.10.5 QMENTA Recent Development
11.11 Cortechs.ai
11.11.1 Cortechs.ai Company Detail
11.11.2 Cortechs.ai Business Overview
11.11.3 Cortechs.ai Brain Disease Device and Software Introduction
11.11.4 Cortechs.ai Revenue in Brain Disease Device and Software Business (2018-2023)
11.11.5 Cortechs.ai Recent Development
11.12 Quantib
11.12.1 Quantib Company Detail
11.12.2 Quantib Business Overview
11.12.3 Quantib Brain Disease Device and Software Introduction
11.12.4 Quantib Revenue in Brain Disease Device and Software Business (2018-2023)
11.12.5 Quantib Recent Development
11.13 Brainomix
11.13.1 Brainomix Company Detail
11.13.2 Brainomix Business Overview
11.13.3 Brainomix Brain Disease Device and Software Introduction
11.13.4 Brainomix Revenue in Brain Disease Device and Software Business (2018-2023)
11.13.5 Brainomix Recent Development
11.14 Qure.AI
11.14.1 Qure.AI Company Detail
11.14.2 Qure.AI Business Overview
11.14.3 Qure.AI Brain Disease Device and Software Introduction
11.14.4 Qure.AI Revenue in Brain Disease Device and Software Business (2018-2023)
11.14.5 Qure.AI Recent Development
11.15 Imaging Biometrics, LLC
11.15.1 Imaging Biometrics, LLC Company Detail
11.15.2 Imaging Biometrics, LLC Business Overview
11.15.3 Imaging Biometrics, LLC Brain Disease Device and Software Introduction
11.15.4 Imaging Biometrics, LLC Revenue in Brain Disease Device and Software Business (2018-2023)
11.15.5 Imaging Biometrics, LLC Recent Development
11.16 A.I. Analysis, Inc
11.16.1 A.I. Analysis, Inc Company Detail
11.16.2 A.I. Analysis, Inc Business Overview
11.16.3 A.I. Analysis, Inc Brain Disease Device and Software Introduction
11.16.4 A.I. Analysis, Inc Revenue in Brain Disease Device and Software Business (2018-2023)
11.16.5 A.I. Analysis, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

United Imaging Healthcare Co., Ltd
Koninklijke Philips N.V.
GE
Canon, Inc
Siemens Healthineers AG
Vuno Co., Ltd
Fujifilm Holdings Corporation
Aspect Imaging
IXICO
QMENTA
Cortechs.ai
Quantib
Brainomix
Qure.AI
Imaging Biometrics, LLC
A.I. Analysis, Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.